Filter
166
Filtered Results: 166
Text search:
blister
agents
Featured
Recommendations
26
New Publications
52
Language
Document type
No document type
107
Guidelines
32
Manuals
13
Studies & Reports
10
Situation Updates
2
Training Material
1
Fact sheets
1
Countries / Regions
India
21
Ethiopia
8
Nigeria
7
Global
5
South Africa
5
Uganda
5
Nepal
4
Kenya
4
Philippines
4
Western and Central Europe
4
Syria
3
USA
3
Tanzania
3
Ghana
2
Benin
2
Cambodia
2
Bangladesh
2
Zambia
2
Indonesia
2
Liberia
2
Madagascar
2
Eswatini/ Swaziland
2
Thailand
1
Ukraine
1
Lesotho
1
Sierra Leone
1
Senegal
1
Burkina Faso
1
Zimbabwe
1
Guinea
1
Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Côte d’Ivoire / Ivory Coast
1
Namibia
1
Iraq
1
Authors & Publishers
Publication Years
Category
Guidelines
32
Drugs & Medical Equipment
22
Capacity Building
19
Policies & Guidelines HIV & TB
15
Women & Child Health
9
Dermatology
5
Surgery & Anaesthesia
5
Public Health
4
Policies
4
Communicable Diseases
4
Paediatrics
3
Diabetes
3
Pediatrics
3
Clinical Guidelines
3
Studies & Reports
3
Gynaecology & Obstetrics
3
Non-communicable Diseases
3
HIV & STI
3
Malaria
3
Dental & Eye Care
2
Community Health
2
Leprosy
2
Waste Management
2
Leprosy
2
NTDs & Others
2
TB
2
Clinical Training
1
Pharmacy & Technology
1
Buruli Ulcer
1
COVID-19
1
Community Health
1
MPOX - Monkeypox
1
Non-communicable Diseases NCD
1
Infection Control & Prevention (IPC)
1
Cardiovascular Diseases
1
Information, Education and Communication (IEC)
1
Disabilities
1
Maternal Health
1
Leishmaniasis
1
Laboratory Quality Assurance
1
Water
1
Age & Elderly
1
Neonatal Care
1
Disease Prevention & Control
1
Toolboxes
Technical Information
6
Essential Medicines & Devices Lists
5
Clinical Guidelines
4
Essential Medicines
4
Falsified & Substandard
4
Waste Managment
4
Surveillance
3
Chemical Attacks
3
Preparedness, Response & Risk Communication
3
Reports & Studies
3
Training
2
Clinical Aspects
2
Adults
2
Training
2
Climate & Health
2
Treatment Guidelines
2
Essential List
2
Waste Management
2
Wound management
2
Pharmacy Management
2
Others
2
Health Impact & Climate Change
2
Nuclear & Chemical Hazards
2
Clinical Aspects & Diagnosis
2
Drug resistant TB
2
Treatment & Clinical Management
2
ART Drug Resistance
1
HIV testing & services
1
Clinical Guidelines
1
IPC
1
Clinical Aspects, Treatment & Prevention
1
Policies & Strategies
1
Treatment & Prevention
1
Training
1
Influenza Prevention & Control
1
Physical Disability
1
Clinical Guidelines
1
Training Manuals
1
Training
1
Stroke
1
Public Health
1
Sexually Transmitted Infections
1
Prevention & Control
1
Hepatitis
1
Adherence
1
Preparedness, Response & Risk Communication
1
Ebola
1
Country Guidelines
1
Ethiopia
1
Country Specific
1
Country specific documents
1
Long-term Care Facilities
1
Preparedness, Response & Risk Communication
1
Long COVID/ Post-COVID Syndrome
1
Standard Operating Procedure (SOP)
1
Others
1
Handbooks & Manuals
1
Community Health Workers CHW
1
Midwives
1
Nurses
1
Climate Change General
1
Prices and Patents
1
Pharmacy Practice
1
Supply Chain & Store Management
1
Quality Assurance
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
Pediatrics
1
Women & Maternal Health
1
Guidelines & Manuals
1
General
1
Health Care In Conflict Settings
1
Waste management
1
MPOX - Monkeypox
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Prevention & Strategies
1
Diagnosis
1
War Surgery & Wound Care
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Prophylactic Treatment
1
Prevention of Disabilites
1
Research & Access
1
Technical Information
1
HIV / AIDS
1
Clinical Guidelines
1
Infection Control
1
Kenya
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
This interim guidance is aimed at healthcare workers who may receive patients
exposed to chemical weapons at their healthcare facilities.
It provides questions to guide the identification of contaminated patients,
recommendations on personal protection, procedures for decontamin...
A Snapshot of European Collection Schemes
A feasibility study in five African sites
With the recent advances in medicine, the survival rate of clients with
severe burns has improved. This has resulted in greater demand for rehabilitation services. One of the major goals for rehabilitation programmes is to restore these clients to their pre-trauma activity levels. However, there is...
A healthcare worker manual. 2nd edition
The development of this National Manual for the Management of HIV-related Opportunistic Infections and Conditions for use by health care workers at the frontline of our fight against HIV/AIDS is intended to improve their understanding of the causes, preventio...
Diabetes mellitus, commonly known as diabetes, is a group of metabolic disorders characterized by the presence of hyperglycaemia in the absence of treatment. The heterogeneous aetiopathology includes defects in insulin secretion, insulin action, or both. The long-term specific complications of diabe...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Depuis les années ‘80, la politique et les pratiques de gestion des déchets ont connu une évolution considérable, tant pour les ménages que pour les entreprises et le secteur public. Plus récemment, l’obligation de tri pour les entreprises est entrée en
vigueur progressivement à partir ...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Technology landscape
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
